Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bystander-based autologous tumor cell vaccine (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (1 total)